参考文献/References:
[1] GUARIGUATA L, WHITING D R, HAMBLETON I,et al. Global estimates of diabetes prevalence for 2013and projections for 2035[J]. Diabetes Research andClinical Practice, 2014, 103(2): 137-149.
[2] NIKPAY M, GOEL A, WON H H, et al. A comprehensive1 000 Genomes-based genome-wide associationmeta-analysis of coronary artery disease[J]. NatureGenetics, 2015, 47(10): 1121-1130.
[3] YANG Y,XU J R,WANG Y J,et al. Association ofTCF7L2 gene polymorphisms with susceptibility totype 2 diabetes mellitus in a Chinese Hui population[J].Genetics and Molecular Research : GMR,2015,14(3):10064-10071.
[4] 杨曼，汪清，洪翔，等．中国人群TCF7L2 基因多态性与2 型糖尿病关系的Meta 分析[J]．中华疾病控制杂志, 2018, 22（5）: 504-509． YANG Man, WANG Qing, HONG Xiang, et al.Meta-analysis of the association between SNPs inTCF7L2 and type 2 diabetes mellitus in China[J].Chinese Journal of Disease Control & Prevention，2018,22（5）:504-509．
[5] WAGNER R, STAIGER H, ULLRICH S, et al. Untanglingthe interplay of genetic and metabolic influenceson beta-cell function:Examples of potential therapeuticimplications involving TCF7L2 and FFAR1[J]. MolecularMetabolism, 2014, 3(3): 261-267.
[6] ZHANG Lu,ZHANG Ming,WANG Jinjin, et al.Association of TCF7L2 and GCG gene variants withinsulin secretion, insulin resistance, and obesity innew-onset diabetes[J].Biomedical and EnvironmentalSciences,2016,29(11):814-817
[7] LUO Yingying, WANG Hongyuan, HAN Xueyao,et al. Meta-analysis of the association betweenSNPs in TCF7L2 and type 2 diabetes in East Asianpopulation[J]. Diabetes Research and Clinical Practice,2009, 85(2): 139-146.
[8] 郭宜晨，鲁亚静，钟伟传，等．2 型糖尿病患者外周血miRNA 表达谱差异研究[J]．现代检验医学杂志, 2018, 33（6）: 5-8． GUO Yichen, LU Yajing, ZHONG Weichuan, et al.Study on the difference of serum miRNA expressionprofile in peripheral blood of patients with type 2diabetes mellitus[J]. Journal of Modern LaboratoryMedicine, 2018,33(6): 5-8.
[9] EL-BARGHOUTI N, ELKELES R, NICOLAIDES A,et al. The ultrasonic evaluation of the carotid intimamediathickness and its relation to risk factors ofatherosclerosis in normal and diabetic population[J].International Angiology : a Journal of the InternationalUnion of Angiology, 1997, 16(1): 50-54.
[10] 张洁．福建汉族人群TCF7L2 基因多态性、机体及环境因素与2 型糖尿病关联性研究[D]．福州：福建医科大学，2015． ZHANG Jie. Correlation study on the associationsbetween TCF7L2 polymorphisms，body factorsand environmental factors with type 2 diabetes inFujian Han Population [D]. Fuzhou：Fujian MedicalUniversity, 2015.
[11] 钟爱丽．延边朝鲜族和汉族TCF7L2 基因SNPs 与2 型糖尿病及原发性高血压相关性研究[D]．延吉：延边大学，2014． ZHONG Aili. The study of the associated betweenSNPs of TCF7L2 gene and the morbidity of type 2diabetes and essential hypertension in Yanbian ChineseKoreans and the Chinese Han [D]. Yanji：YanbianUniversity, 2014.
[12] 张江峰，曾照芳．TCF7L2 基因rs11196205 多态性与重庆市汉族人群2 型糖尿病的关联研究[J]. 激光杂志, 2011, 32（6）: 90-92． ZHANG Jiangfeng, ZENG Zhaofang. A study on theassociation between variant of rs11196205 in TCF7L2gene and type 2 diabetes mellitus in Chongqing Hanpopulation [J]. Laser Journal, 2011, 32 (6): 90-92.
[13] GRAVAND A, FOROUGHM A, BOROUJENI M P.A study on the association of TCF7L2 rs11196205 (C/G) and CAPN10 rs3792267 (G/A) polymorphisms withtype 2 diabetes mellitus in the South Western of Iran[J].Egyptian Journal of Medical Human Genetics,2018,19(4): 403-407.
[14] HUERTAS-VAZQUEZ A, PLAISIER C, WEISSGLAS-VOLKOV D, et al. TCF7L2 is associated with highserum triacylglycerol and differentially expressedin adipose tissue in families with familial combinedhyperlipidaemia[J]. Diabetologia, 2008,51(1): 62-69.
[15] 赵晓宇，周钟玉，曹黎，等．中国北方人群TCF7L2基因多态性与血脂谱的相关性[J]．现代生物医学进展, 2016, 16（27）: 5219-5222, 5240． ZHAO Xiaoyu, ZHOU Zhongyu, CAO Li, et al. Theassociation between TCF7L2 polymorphisms andlipid Profile in northern China[J]. progress in ModernBiomedicine, 2016, 16(27): 5219-5222,5240.
[16] 朱晖，王佑民，许敏，等．转录因子7 类似物2 基因rs11196205 多态性与安徽地区2 型糖尿病及糖调节受损的相关性[J]. 中华糖尿病杂志, 2010, 2（3）:210-215． ZHU Hui, WANG Youmin, XU Min, et al. Variant ofrs11196205 in TCF7L2 gene may be associated withtype 2 diabetes and impaired glucose regulation inAnhui,China[J]. Chinese Journal of Diabetes Mellitus,2010, 2(3): 210-215.
相似文献/References:
[1]韩登科,房绮梅,谢晋烨,等.2 型糖尿病并发高血压患者血清Fetuin B 水平检测及与Hcy 浓度的相关性研究[J].现代检验医学杂志,2020,35(02):24.[doi:10.3969 ／ j.issn.1671-7414.2020.02.008]
HAN Deng-ke,FANG Qi-mei,XIE Jin-ye,et al.Serum Fetuin B Level in Patients with Type 2 Diabetes Mellitus Complicated withHypertension and Its Correlation with Hcy Concentration were Investigated[J].Journal of Modern Laboratory Medicine,2020,35(04):24.[doi:10.3969 ／ j.issn.1671-7414.2020.02.008]
[2]刘肖瑛,林佩娜,欧阳伟庆,等.2 型糖尿病患者血清sdLDL 和脂类水平及相关性分析[J].现代检验医学杂志,2020,35(03):58.[doi:10.3969/j.issn.1671-7414.2020.03.014]
LIU Xiao-ying,LIN Pei-na,OUYANG Wei-qing,et al.Analysis of Serum sdLDL and Lipid Levels and Their Correlation in
Patients with Type 2 Diabetes[J].Journal of Modern Laboratory Medicine,2020,35(04):58.[doi:10.3969/j.issn.1671-7414.2020.03.014]
[3]洪雄新,李观强,杨 辉,等.2 型糖尿病患者ABCA1 R219K 基因多态性分布及其与血脂水平的相关性研究[J].现代检验医学杂志,2020,35(04):14.[doi:10.3969/j.issn.1671-7414.2020.04.004]
HONG Xiong-xin,LI Guan-qiang,YANG Hui,et al.Study on Distribution of ABCA1 R219K Gene Polymorphism and Its Correlation with Blood Lipid Levels for Type 2 Diabetes Mellitus Patients[J].Journal of Modern Laboratory Medicine,2020,35(04):14.[doi:10.3969/j.issn.1671-7414.2020.04.004]
[4]杨莉婷,陈 翠,蒋兴亮.2 型糖尿病患者血清残余胆固醇水平与超敏C 反应蛋白表达的相关性研究[J].现代检验医学杂志,2020,35(04):45.[doi:10.3969/j.issn.1671-7414.2020.04.011]
YANG Li-ting,CHEN Cui,JIANG Xing-liang.Association between Serum Remnant Cholesterol Levels and Expression of High Sensitive C-reactive Protein in Patients with Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2020,35(04):45.[doi:10.3969/j.issn.1671-7414.2020.04.011]
[5]张海霞a,郭 杰a,袁 宁a,等.老年健康体检人群外周血红细胞分布宽度与糖化血红蛋白A1c 的相关性研究[J].现代检验医学杂志,2020,35(04):65.[doi:10.3969/j.issn.1671-7414.2020.04.016]
ZHANG Hai-xia a,GUO Jiea,YUAN Ninga,et al.Association of Peripheral Blood Red Blood Cell Distribution Width with Glycated Hemoglobin A1c in the Healthy Elderly Population for Check-ups[J].Journal of Modern Laboratory Medicine,2020,35(04):65.[doi:10.3969/j.issn.1671-7414.2020.04.016]
[6]张 艳a,刘 翔a,李鸿钏a,等.血清脂蛋白磷脂酶A2 和血浆抗凝血酶Ⅲ对2 型糖尿病患者发生缺血性脑卒中风险的评估价值[J].现代检验医学杂志,2020,35(04):71.[doi:10.3969/j.issn.1671-7414.2020.04.017]
ZHANG Yana,LIU Xianga,LI Hong-chuana,et al.Evaluation Value of Serum Lipoprotein-Associated Phospholipase A2 and Plasma Antithrombin Ⅲ on the Risk of Ischemic Stroke in Patients with Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2020,35(04):71.[doi:10.3969/j.issn.1671-7414.2020.04.017]
[7]张 凯,李全双,程 星.2 型糖尿病患者血清低清蛋白水平对糖化清蛋白检测结果的影响[J].现代检验医学杂志,2020,35(04):126.[doi:10.3969/j.issn.1671-7414.2020.04.032]
ZHANG Kai,LI Quan-shuang,CHENG Xing.Effect of Serum Low Albumin Level on the Detection of Glycosylated Albumin in Patients with Type 2 Ddiabetes Mellitus[J].Journal of Modern Laboratory Medicine,2020,35(04):126.[doi:10.3969/j.issn.1671-7414.2020.04.032]
[8]刘倩倩,鲁作华,王 星,等.血浆D- 二聚体在2 型糖尿病患者早期肾损伤中的应用价值[J].现代检验医学杂志,2020,35(04):134.[doi:10.3969/j.issn.1671-7414.2020.04.034]
LIU Qian-qian,LU Zuo-hua,WANG Xing,et al.Application Value of Serum D-Dimer in Early Kidney Injury in Patients with Type 2 Diabetes[J].Journal of Modern Laboratory Medicine,2020,35(04):134.[doi:10.3969/j.issn.1671-7414.2020.04.034]
[9]欧阳清慧,王 冰,杨自力,等.四川省绵阳地区慢性丙型肝炎患者继发2 型糖尿病危险因素分析[J].现代检验医学杂志,2020,35(04):151.[doi:10.3969/j.issn.1671-7414.2020.04.038]
OUYANG Qing-hui,WANG Bing,YANG Zi-li,et al.Analysis of Risk factors of Chronic Hepatitis C Complicated with Type 2 Diabetes Mellitus in Mianyang of Sichuan[J].Journal of Modern Laboratory Medicine,2020,35(04):151.[doi:10.3969/j.issn.1671-7414.2020.04.038]
[10]陈树鑫a,宁 晔a,韩登科b.2 型糖尿病患者血清 Fetuin B 水平与并发下肢动脉粥样硬化性病变的相关性研究[J].现代检验医学杂志,2020,35(06):21.[doi:doi:10.3969/j.issn.1671-7414.2020.06.006]
CHEN Shu-xin a,NING Ye a,HAN Deng-ke b.Relationship between Serum Fetuin B Level and Atherosclerotic Lesions inLower Limb of Patients with Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2020,35(04):21.[doi:doi:10.3969/j.issn.1671-7414.2020.06.006]